Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Chemoradiation +/- Induction or Consolidation Chemotherapy in Stage III NSCLC
NCT01652820Phase 2Completed
- Sponsor
- Fundación GECP
- Start
- Oct 2001
- Primary completion
- Jul 2006
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of docetaxel, gemcitabine, carboplatin in non-small cell lung cancer (NSCLC), sponsored by Fundación GECP. Started Oct 2001; status: completed.
02
Drugs
docetaxelgemcitabinecarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01652820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652820.